[ESC高血压指南2024:针对高风险患者]
Virginie Tacchini1, Kevin Dobretz1, Anne Bevand1
1Service de cardiologie, Hôpitaux universitaires de Genève, 1211 Genève 14.
Revue medicale suisse
|September 12, 2025
概括
欧洲心脏病学会在2024年发布了新的高血压指南,重点关注高风险患者和个性化护理,以更好地管理血压和减少心血管事件.
科学领域:
- 心脏病学 心脏病学
- 高血压管理 高血压管理
- 评估心血管风险评估
背景情况:
- 高血压 (BP) 和高血压 (HTN) 仍然是全球重大健康挑战.
- 目前的管理策略需要更新,以反映不断变化的心血管风险理解.
- 欧洲心脏病学会 (ESC) 定期修订指南,以优化患者护理.
研究的目的:
- 总结了2024年ESC指南中对高BP和HTN引入的关键变化.
- 突出重点关注高心血管风险患者和个性化治疗方法.
- 概述欧洲经济委员会关于改善血压管理的最新战略.
主要方法:
- 审查新发布的2024年欧洲心脏病学会 (ESC) 指南.
- 对高血压的诊断标准和治疗算法提出的变化的分析.
- 确定针对特定患者群体的建议,特别是高心血管风险患者.
主要成果:
- 在高血压和高血压的管理中引入了重大修改.
- 强调风险分层,以确定从干预中获益最多的患者.
- 整合个性化护理原则,以定制治疗和诊断途径.
结论:
- 2024年ESC指南代表了优化血压管理的一步.
- 个性化护理和专注于降低心血管风险是新建议的核心.
- 需要持续努力才能实现消除心血管事件的最终目标.
相关概念视频
Hypertension I: Introduction
748
Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
748
Hypertension V: Nursing Management
366
The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
366
Hypertension IV: Drug Therapy and Lifestyle Modifications
624
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
624
Hypertension III: Clinical Manifestations and Diagnostic Studies
472
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
472
Hypertension and Regulation of Blood Pressure
3.8K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.8K
Heart Failure V: Medical Management
223
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
223


